Covid Trials for Kids Get Started With First Results by Mid-2021

Jan. 19, 2021, 9:56 AM

William Brown has yet to set foot in a classroom during his freshman year of high school -- kept at home, like many students, by the pandemic.

Days before Christmas, he took a step that could help him and other youngsters return to school sooner. With his parents’ encouragement, the 15-year-old signed up for a trial of Pfizer Inc.’s vaccine in adolescents.

“I miss seeing all my friends, and being in person, talking to my teachers,” Brown said by phone from Raleigh, North Carolina. “Hopefully, me doing this will allow people my age to get back to school.”

In ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.